(内容请参阅英文版)
Following the success of GLP-1 drugs, OBPHARM Limited is developing Hong Kong's first "magic pill" to fight obesity. After 25 years of research, this breakthrough drug promises to revolutionise how obesity is treated - offering a safer, more effective solution. With huge global demand, OBPHARM is poised to lead the next wave in weight-loss medicine and tap into a vast, rapidly growing market.
Principal Investigator(s)
Prof. Yu WANG
Professor,
Department of Pharmacology
LKS Faculty of Medicine
Prof. Xuechen LI
Professor, Chair of Medical Chemistry and Chemical Biology
Morningside Endowed Professor
Department of Chemistry
Faculty of Science
Email: yuwanghk@hku.hk; xuechenl@hku.hk
Achievements and Awards
Ideation and IncuBio of HKSTP program
Learn More About This Technology Offering:
